BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 28951560)

  • 21. Protein kinase CK2: a potential therapeutic target for diverse human diseases.
    Borgo C; D'Amore C; Sarno S; Salvi M; Ruzzene M
    Signal Transduct Target Ther; 2021 May; 6(1):183. PubMed ID: 33994545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Raf-1/CK2 and RhoA/ROCK signaling promote TNF-α-mediated endothelial apoptosis via regulating vimentin cytoskeleton.
    Yang L; Tang L; Dai F; Meng G; Yin R; Xu X; Yao W
    Toxicology; 2017 Aug; 389():74-84. PubMed ID: 28743511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effects of a Selective CK2 Inhibitor on Anti-glomerular Basement Membrane Glomerulonephritis in Rats.
    Shi J; Liu N; Xiao Y; Takei Y; Yasue M; Suzuki Y; Hou Z; Ohno H; Yamada M; Fuchi N; Oshida K; Miyamoto Y; Tsujimoto G; Hirasawa A
    Biol Pharm Bull; 2015; 38(9):1345-51. PubMed ID: 26328489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of taurine homeostasis by protein kinase CK2 in mouse fibroblasts.
    Hansen DB; Guerra B; Jacobsen JH; Lambert IH
    Amino Acids; 2011 Apr; 40(4):1091-106. PubMed ID: 20827495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of 4,5,6,7-tetrahalogeno-1H-isoindole-1,3(2H)-diones as inhibitors of human protein kinase CK2.
    Golub AG; Yakovenko OY; Prykhod'ko AO; Lukashov SS; Bdzhola VG; Yarmoluk SM
    Biochim Biophys Acta; 2008 Jan; 1784(1):143-9. PubMed ID: 18021749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of protein kinase CK2 in intestinal epithelial cell inflammatory signaling.
    Parhar K; Morse J; Salh B
    Int J Colorectal Dis; 2007 Jun; 22(6):601-9. PubMed ID: 17009010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein response.
    Manni S; Brancalion A; Tubi LQ; Colpo A; Pavan L; Cabrelle A; Ave E; Zaffino F; Di Maira G; Ruzzene M; Adami F; Zambello R; Pitari MR; Tassone P; Pinna LA; Gurrieri C; Semenzato G; Piazza F
    Clin Cancer Res; 2012 Apr; 18(7):1888-900. PubMed ID: 22351691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repressing the activity of protein kinase CK2 releases the brakes on mitochondria-mediated apoptosis in cancer cells.
    Hanif IM; Pervaiz S
    Curr Drug Targets; 2011 Jun; 12(6):902-8. PubMed ID: 21269261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of CK2 enhances UV-triggered apoptotic cell death in lung cancer cell lines.
    Zhao T; Jia H; Li L; Zhang G; Zhao M; Cheng Q; Zheng J; Li D
    Oncol Rep; 2013 Jul; 30(1):377-84. PubMed ID: 23595577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic anti-leukemic effects of CK2 inhibitors and pentabromobenzylisothioureas in vitro.
    Koronkiewicz M; Chilmonczyk Z; Kazimierczuk Z
    Anticancer Res; 2013 Nov; 33(11):4891-9. PubMed ID: 24222126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Casein Kinase II: an attractive target for anti-cancer drug design.
    Hanif IM; Hanif IM; Shazib MA; Ahmad KA; Pervaiz S
    Int J Biochem Cell Biol; 2010 Oct; 42(10):1602-5. PubMed ID: 20558317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The dark side of protein kinase CK2 inhibition.
    Cozza G; Meggio F; Moro S
    Curr Med Chem; 2011; 18(19):2867-84. PubMed ID: 21651492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Addiction to protein kinase CK2: a common denominator of diverse cancer cells?
    Ruzzene M; Pinna LA
    Biochim Biophys Acta; 2010 Mar; 1804(3):499-504. PubMed ID: 19665589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein kinase CK2.
    Pinna LA
    Int J Biochem Cell Biol; 1997 Apr; 29(4):551-4. PubMed ID: 9363631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of protein kinase CK2 in the regulation of tumor necrosis factor-related apoptosis inducing ligand-induced apoptosis in prostate cancer cells.
    Wang G; Ahmad KA; Ahmed K
    Cancer Res; 2006 Feb; 66(4):2242-9. PubMed ID: 16489027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CIGB-300: A peptide-based drug that impairs the Protein Kinase CK2-mediated phosphorylation.
    Perea SE; Baladrón I; Valenzuela C; Perera Y
    Semin Oncol; 2018 Jan; 45(1-2):58-67. PubMed ID: 30318085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of mitoxantrone on the activity of human protein kinase CK2 holoenzyme].
    Li CM; Liu XG; Lin XC; Chen XW; Liang NC
    Ai Zheng; 2008 Aug; 27(8):809-15. PubMed ID: 18710613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein signaling and regulation of gene transcription in leukemia: role of the Casein Kinase II-Ikaros axis.
    Gowda CS; Song C; Ding Y; Kapadia M; Dovat S
    J Investig Med; 2016 Mar; 64(3):735-9. PubMed ID: 26912004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2.
    Spinello Z; Fregnani A; Quotti Tubi L; Trentin L; Piazza F; Manni S
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative analysis of CK2 expression and function in tumor cell lines displaying sensitivity vs. resistance to chemical induced apoptosis.
    Di Maira G; Brustolon F; Tosoni K; Belli S; Krämer SD; Pinna LA; Ruzzene M
    Mol Cell Biochem; 2008 Sep; 316(1-2):155-61. PubMed ID: 18560764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.